GTEX-13SLX
|
51-60
|
Female
|
GTEX-13SLX-1226 |
Liver
|
PAXgene |
1
|
2 pieces; periportal fibrosis with chronic inflammation and early bridging fibrosis
|
Acceptable
|
 |
GTEX-13VXU
|
51-60
|
Male
|
GTEX-13VXU-0926 |
Liver
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
GTEX-13W46
|
51-60
|
Male
|
GTEX-13W46-1026 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, agonal necrosis
|
Acceptable
|
 |
GTEX-13X6I
|
61-70
|
Male
|
GTEX-13X6I-1626 |
Liver
|
PAXgene |
1
|
2 pieces; cirrhosis, cholestatic features
|
Acceptable
|
 |
GTEX-13X6J
|
51-60
|
Male
|
GTEX-13X6J-1826 |
Liver
|
PAXgene |
1
|
2 pieces; marked steatosis and congestion
|
Acceptable
|
 |
GTEX-13X6K
|
61-70
|
Female
|
GTEX-13X6K-1126 |
Liver
|
PAXgene |
1
|
2 pieces, no significant steatosis/congestion
|
Acceptable
|
 |
GTEX-13YAN
|
61-70
|
Male
|
GTEX-13YAN-1626 |
Liver
|
PAXgene |
1
|
2 pieces, marked centrilobular congestion/cardiac 'cirrhosis'
|
Acceptable
|
 |
GTEX-1445S
|
61-70
|
Male
|
GTEX-1445S-0926 |
Liver
|
PAXgene |
2
|
2 pieces, moderate steatosis, bridging fibrosis
|
Acceptable
|
 |
GTEX-144FL
|
51-60
|
Male
|
GTEX-144FL-1326 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse infiltrative process suggestive of amyloid
|
Unacceptable
|
 |
GTEX-144GL
|
51-60
|
Male
|
GTEX-144GL-1426 |
Liver
|
PAXgene |
1
|
2 pieces; 20% macrovesicular steatosis
|
Acceptable
|
 |
GTEX-144GM
|
21-40
|
Male
|
GTEX-144GM-1326 |
Liver
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
GTEX-144GO
|
61-70
|
Male
|
GTEX-144GO-1126 |
Liver
|
PAXgene |
2
|
2 pieces; 10-20% of each is large vessels/nerve/fibrous tissue
|
Acceptable
|
 |
GTEX-145LS
|
61-70
|
Female
|
GTEX-145LS-0926 |
Liver
|
PAXgene |
1
|
2 pieces; minimal fat
|
Acceptable
|
 |
GTEX-145LU
|
41-50
|
Male
|
GTEX-145LU-1326 |
Liver
|
PAXgene |
1
|
2 pieces; 10% macrovesicular steatosis
|
Acceptable
|
 |
GTEX-145MF
|
41-50
|
Male
|
GTEX-145MF-0826 |
Liver
|
PAXgene |
1
|
2 pieces, mild congestion, mild chronic hepatitis. No significant steatosis.
|
Acceptable
|
 |
GTEX-145MG
|
51-60
|
Male
|
GTEX-145MG-1326 |
Liver
|
PAXgene |
1
|
2 pieces; <5% fat
|
Acceptable
|
 |
GTEX-145MH
|
51-60
|
Male
|
GTEX-145MH-2126 |
Liver
|
PAXgene |
2
|
2 pieces; mild steatosis
|
Acceptable
|
 |
GTEX-145MI
|
61-70
|
Female
|
GTEX-145MI-1226 |
Liver
|
PAXgene |
2
|
2 pieces; 50% macrovesiculer steatosis
|
Acceptable
|
 |
GTEX-145MO
|
61-70
|
Male
|
GTEX-145MO-2326 |
Liver
|
PAXgene |
1
|
2 pieces moderate congestion; no significant steatosis or hepatitis noted
|
Acceptable
|
 |
GTEX-146FH
|
51-60
|
Female
|
GTEX-146FH-1526 |
Liver
|
PAXgene |
1
|
2 pieces; 80% macrovesicular steatosis, portal inflammation and bridging fibrosis consistent with nonalcoholic steatohepatitis
|
Acceptable
|
 |
GTEX-14753
|
61-70
|
Male
|
GTEX-14753-1626 |
Liver
|
PAXgene |
1
|
2 pieces; moderate centrilobular congestion
|
Acceptable
|
 |
GTEX-1477Z
|
61-70
|
Male
|
GTEX-1477Z-0526 |
Liver
|
PAXgene |
1
|
2 pieces, moderate congestion, no steatosis/hepatitis noted
|
Acceptable
|
 |
GTEX-147F4
|
41-50
|
Male
|
GTEX-147F4-1426 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
 |
GTEX-147GR
|
61-70
|
Male
|
GTEX-147GR-1326 |
Liver
|
PAXgene |
1
|
2 pieces: moderate central congestion
|
Acceptable
|
 |
GTEX-147JS
|
61-70
|
Male
|
GTEX-147JS-1126 |
Liver
|
PAXgene |
1
|
2 pieces, mild congestion; ~10% macrovesicular parenchymal fat
|
Acceptable
|
 |